Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Clinical trial tests AI-assisted medication device for older adults with memory loss
United Kingdom
-
A Swarm of Seven Meteor Showers Will Light Up the Night Skies All October Long
United Kingdom
-
Ocean, desert rainfall and a parasitic disease: Researchers connect patterns
United Kingdom
-
'Herd-Immunity-on-a-Chip' recreates viral transmission within a simulated population
United Kingdom
-
Early warning signs of chronic pelvic pain may appear in adolescence, study finds
United Kingdom
-
Sauna rituals and expansion plans feature strongly in early bathhouse survey findings
United States
-
Years of opioid use do not improve chronic back pain, study finds
United Kingdom
-
Improving early detection of cognitive impairment in primary care
United Kingdom